Library / Laws / 116th Congress / House Bills / H.R. 2038
H.R. 2038
To allow State-based, market-oriented, prescription drug negotiations to lower pharmaceutical drug prices, to encourage competition, to increase consumer choice and access, and for other purposes.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in House | 2019-04-02 | 3.0K | ⠃⠗⠋ |